Patents by Inventor Anastasia Diamandi

Anastasia Diamandi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060121542
    Abstract: Method of monitoring or diagnosing disease conditions, including disease of the prostrate, that involve measuring a combination of tumor markers and at least one component of the IGF axis. The invention is exemplified with prostate cancer and benign prostrate hyperplasia, the tumor marker prostate specific antigen and the insulin-like growth factors and their binding proteins.
    Type: Application
    Filed: January 25, 2006
    Publication date: June 8, 2006
    Inventors: M. Khosravi, Anastasia Diamandi, Jehangir Mistry
  • Publication number: 20030017513
    Abstract: Method of monitoring or diagnosing disease conditions, including disease of the prostrate, that involve measuring a combination of tumour markers and at least one component of the IGF axis. The invention is exemplified with prostate cancer and benign prostatic hyperplasia, the tumor marker prostate specific antigen, and the insulin-like growth factors and their binding proteins.
    Type: Application
    Filed: March 7, 2002
    Publication date: January 23, 2003
    Applicant: Diagnostic System Laboratories, Inc.
    Inventors: M. Javad Khosravi, Anastasia Diamandi, Jehangir Mistry
  • Patent number: 6448086
    Abstract: Method of monitoring or diagnosing disease conditions, including disease of the prostate, that involve measuring a combination of tumor markers and at least one component of the IGF axis. The invention is exemplified with prostate cancer and benign prostatic hyperplasia, the tumor marker prostate specific antigen, and the insulin-like growth factors and their binding proteins.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: September 10, 2002
    Assignee: Diagnostic Systems Laboratories, Inc.
    Inventors: M. Javad Khosravi, Anastasia Diamandi, Jehangir Mistry
  • Patent number: 6348323
    Abstract: The present invention relates to screening or testing for insulin like growth factors, insulin like growth factor binding proteins and/or acid labile subunit by the use of a solid support. Blood is collected onto a solid support, such as paper, and subsequently the analytes of interest are extracted for testing.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: February 19, 2002
    Assignee: Diagnostic Systems Laboratories, Inc.
    Inventors: M. Javad Khosravi, Jehangir Mistry, Anastasia Diamandi
  • Patent number: 6248546
    Abstract: A method of assaying the growth hormone status of an individual by immuno-assay for the 150 KDa Insulin-like Growth Factor ternary complex (IGF/IGFBP-3/ALS). Alternatively, a binary complex may be assayed. The method involves capturing the IGFBP complex with a first antibody coupled to a solid phase and detecting the complex with a second antibody coupled to a label. A set of monoclonal and polyclonal antibodies usefutl for the assay is also provided.
    Type: Grant
    Filed: March 9, 1998
    Date of Patent: June 19, 2001
    Assignee: Diagnostic Systems Laboratories, Inc.
    Inventors: M. Javad Khosravi, Anastasia Diamandi, Jehangir Mistry
  • Patent number: 6066464
    Abstract: The present invention relates to screening or testing for insulin like growth factors, insulin like growth factor binding proteins and/or acid labile subunit by the use of a solid support. Blood is collected onto a solid support, such as paper, and subsequently the analytes of interest are extracted for testing.
    Type: Grant
    Filed: December 10, 1996
    Date of Patent: May 23, 2000
    Assignee: Diagnostic Systems Laboratories, Inc.
    Inventors: M. Javad Khosravi, Jehangir Mistry, Anastasia Diamandi
  • Patent number: 5747273
    Abstract: The present invention is for an immunoassay for the measurement of total insulin-like growth factor binding protein-1 (IGFBP-1) and is unaffected by the degree of phosphorylation of the protein. The invention is also for an immunoassay for assessing the phosphorylated variants of IGFBP-1.
    Type: Grant
    Filed: May 7, 1996
    Date of Patent: May 5, 1998
    Assignee: Diagnostic Systems Laboratories, Inc.
    Inventors: M. Javad Khosravi, Jehangir Mistry, Anastasia Diamandi